|
Volumn 19, Issue SUPPL. 5, 2000, Pages 25-30
|
Clinical beneficts of a metabolic approach in the management of coronary patients
a |
Author keywords
Angina treatment; Cardiac metabolism
|
Indexed keywords
ANTIANGINA PECTORIS AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DILTIAZEM;
NIFEDIPINE;
NITRATE;
PROPRANOLOL;
TRIMETAZIDINE;
ANGINA PECTORIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONGESTIVE HEART FAILURE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DRUG EFFICACY;
DRUG MECHANISM;
EXERCISE TOLERANCE;
HEART LEFT VENTRICLE FAILURE;
HEART MUSCLE REVASCULARIZATION;
HEART PROTECTION;
HEART WORK;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
META ANALYSIS;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
STRESS ECHOCARDIOGRAPHY;
DIABETES MELLITUS;
DRUG COMBINATION;
HEART LEFT VENTRICLE FUNCTION;
HEART MUSCLE REPERFUSION;
METABOLISM;
REVIEW;
CORONARY DISEASE;
DIABETES COMPLICATIONS;
DRUG THERAPY, COMBINATION;
HUMANS;
MYOCARDIAL REPERFUSION;
TRIMETAZIDINE;
VENTRICULAR DYSFUNCTION, LEFT;
|
EID: 0034524402
PISSN: 08702551
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (2)
|
References (24)
|